PRESS RELEASE published on 02/09/2026 at 15:42, 4 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 4.93% stake in Just Group plc as of 06 February 2026. Purchase of 18,342 securities at 2.16 GBP per unit disclosed Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Just Group Plc
PRESS RELEASE published on 02/09/2026 at 15:40, 4 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc. Details of the acquisition include purchases of 1p ordinary shares at 2.03 GBP and 2.04 GBP per unit Financial Transactions The Vanguard Group Stake Disclosure Share Acquisition Spire Healthcare Group Plc
BRIEF published on 02/09/2026 at 15:40, 4 months 21 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Takeover Code Vanguard Group Securities Holding JTC Plc
BRIEF published on 02/09/2026 at 15:40, 4 months 21 days ago Le groupe Vanguard révèle sa participation dans JTC plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Titres Détenus JTC Plc
PRESS RELEASE published on 02/09/2026 at 15:39, 4 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc through form 8.3. Details of securities owned and recent dealings provided Securities Form 8.3 The Vanguard Group Dealings Beazley Plc
PRESS RELEASE published on 02/09/2026 at 15:37, 4 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.95% stake in Avadel Pharmaceuticals plc as of 06/02/2026. Transactions include purchases and sales of US$0.01 ordinary shares Transactions The Vanguard Group, Inc. Stake Disclosure Avadel Pharmaceuticals Plc US$0.01 Ordinary Shares
PRESS RELEASE published on 02/09/2026 at 15:35, 4 months 21 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc via Form 8.3 under Rule 8.3 of the Takeover Code Takeover Code Vanguard Group Financial Disclosure Form 8.3 Disclosure JTC Plc
BRIEF published on 02/06/2026 at 15:29, 4 months 24 days ago The Vanguard Group Discloses Stake in NCC Group plc The Vanguard Group Takeover Code Equity Investment Stake Disclosure NCC Group Plc
BRIEF published on 02/06/2026 at 15:29, 4 months 24 days ago Le groupe Vanguard révèle sa participation dans NCC Group plc Code De Prise De Contrôle Le Groupe Vanguard Investissement En Actions NCC Group Plc Déclaration Des Participations
BRIEF published on 02/06/2026 at 15:25, 4 months 24 days ago The Vanguard Group Discloses Interest in JTC plc Ordinary Shares Form 8.3 Takeover Code Vanguard Group JTC Plc
Published on 06/30/2026 at 15:00, 2 hours 22 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 2 hours 22 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 2 hours 22 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 2 hours 52 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 3 hours 22 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:34, 47 minutes ago hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:05, 1 hour 16 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 15:06, 2 hours 15 minutes ago 260630 BENETEAU Transactions sur actions propres
Published on 06/30/2026 at 07:30, 9 hours 52 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 9 hours 52 minutes ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
